(DE000UD137W6) on GlaxoSmithKline / Merck & Co. / Novo Nordisk

Rating: S&P A+ | Moody’s Aa3 | Fitch A+

ISIN: DE000UD137W6 SSPA product type:: Express Certificates (1260)

Last update 03.05.2022

Bid

-- EUR
Volume: 10

Secondary Market

Prospectus (IT)
Prospectus (EN)

Information on UBS
Terms of use
Privacy statement
Report fraudulent mail
KeyInvest Disclaimer

Important legal and regulatory information. The use and access of these web pages, or any other linked web sites provided by UBS AG and/or any subsidiary